How Site and Principal Investigator Selection can be Re-framed by Utilizing Lab Data

How Site and Principal Investigator Selection can be Re-framed by Utilizing Lab Data

Don’t miss insights into improving your clinical trials via lab data. David Freeman, General Manager, Healthcare Analytics Solutions, Quest Diagnostics, joins Citeline for an informative discussion.

Get answers to questions like:

  • What are the challenges sponsors face when identifying trial sites and principal investigators?
  • Why is it important to identify the right sites and PIs for clinical trials?
  • How can lab data help to ID the best sites and PIs and optimize trials?
  • How can insights gained from lab data impact decisions on clinical trial design?
  • Does harnessing lab data have the potential to make clinical trials more patient-centric?


Whitepaper

Complete the form below to download the content.

* - marks a required field

Answer the following questions about your organization below:


Company

© 2024 Software Trends. All rights reserved.